198 related articles for article (PubMed ID: 19553661)
1. Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18.
Argiriadi MA; Xiang T; Wu C; Ghayur T; Borhani DW
J Biol Chem; 2009 Sep; 284(36):24478-89. PubMed ID: 19553661
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide.
Afonin PV; Fokin AV; Tsygannik IN; Mikhailova IY; Onoprienko LV; Mikhaleva II; Ivanov VT; Mareeva TY; Nesmeyanov VA; Li N; Pangborn WA; Duax WL; Pletnev VZ
Protein Sci; 2001 Aug; 10(8):1514-21. PubMed ID: 11468348
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
4. The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β.
Rondeau JM; Ramage P; Zurini M; Gram H
MAbs; 2015; 7(6):1151-60. PubMed ID: 26284424
[TBL] [Abstract][Full Text] [Related]
5. The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups.
Haji-Ghassemi O; Müller-Loennies S; Rodriguez T; Brade L; Grimmecke HD; Brade H; Evans SV
J Biol Chem; 2016 May; 291(19):10104-18. PubMed ID: 26933033
[TBL] [Abstract][Full Text] [Related]
6. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β.
Blech M; Peter D; Fischer P; Bauer MM; Hafner M; Zeeb M; Nar H
J Mol Biol; 2013 Jan; 425(1):94-111. PubMed ID: 23041424
[TBL] [Abstract][Full Text] [Related]
7. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
8. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
Monaco-Malbet S; Berthet-Colominas C; Novelli A; Battaï N; Piga N; Cheynet V; Mallet F; Cusack S
Structure; 2000 Oct; 8(10):1069-77. PubMed ID: 11080628
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for recognition of CD20 by therapeutic antibody Rituximab.
Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Huo S; Guo Y; Ding J
J Biol Chem; 2007 May; 282(20):15073-80. PubMed ID: 17395584
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
Mylvaganam SE; Paterson Y; Getzoff ED
J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray diffraction analysis of antigen-binding fragments which are specific for antigenic conformations of sialic acid homopolymers.
Patenaude SI; Vijay SM; Yang QL; Jennings HJ; Evans SV
Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):1005-7. PubMed ID: 9757121
[TBL] [Abstract][Full Text] [Related]
12. Structural comparison of different antibodies interacting with parvovirus capsids.
Hafenstein S; Bowman VD; Sun T; Nelson CD; Palermo LM; Chipman PR; Battisti AJ; Parrish CR; Rossmann MG
J Virol; 2009 Jun; 83(11):5556-66. PubMed ID: 19321620
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody.
Beyer BM; Ingram R; Ramanathan L; Reichert P; Le HV; Madison V; Orth P
J Mol Biol; 2008 Oct; 382(4):942-55. PubMed ID: 18708069
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the HIV-2 neutralizing Fab fragment 7C8 with high specificity to the V3 region of gp125.
Uchtenhagen H; Friemann R; Raszewski G; Spetz AL; Nilsson L; Achour A
PLoS One; 2011 Apr; 6(4):e18767. PubMed ID: 21541316
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
[TBL] [Abstract][Full Text] [Related]
16. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
17. Structure of IL-17A in complex with a potent, fully human neutralizing antibody.
Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C
J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab.
Luo J; Wu SJ; Lacy ER; Orlovsky Y; Baker A; Teplyakov A; Obmolova G; Heavner GA; Richter HT; Benson J
J Mol Biol; 2010 Oct; 402(5):797-812. PubMed ID: 20691190
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of recognition of human osteopontin by 23C3, a potential therapeutic antibody for treatment of rheumatoid arthritis.
Du J; Hou S; Zhong C; Lai Z; Yang H; Dai J; Zhang D; Wang H; Guo Y; Ding J
J Mol Biol; 2008 Oct; 382(4):835-42. PubMed ID: 18694758
[TBL] [Abstract][Full Text] [Related]
20. Structural mechanism of the antigen recognition by the L1 cell adhesion molecule antibody A10-A3.
Wei CH; Lee ES; Jeon JY; Heo YS; Kim SJ; Jeon YH; Kim KH; Hong HJ; Ryu SE
FEBS Lett; 2011 Jan; 585(1):153-8. PubMed ID: 21094640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
